Seismic Hopes To Shake Up Immunology With New Financing

 
• By Alaric DeArment

Financing Snapshot: The AI/ML-focused company raised $101m in a series A round and plans to use the funding to develop immunoglobulin- and cell-mediated autoimmune disorder drugs.

AI hand reaches
Seismic announced a $101m series A that it will put toward its machine learning-based development program • Source: Shutterstock

More from Financing

More from Business